Thomas Lynch finds a new home as leader of the Fred Hutch — and he’s staying focused on cancer breakthroughs
Thomas Lynch didn’t last long in the pressure-packed R&D world of Big Pharma R&D, but that doesn’t mean he’s out of the spotlight. Lynch, former head of research at Bristol-Myers Squibb, will now vault to the top of the Fred Hutch in Seattle, one of the most notable research institutions in the world.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 84,700+ biopharma pros reading Endpoints daily — and it's free.